Zusammenfassung
Die chirurgische Therapie des Pankreaskarzinoms muss die komplette Tumorentfernung zum Ziel haben. Dies kann bei lokal begrenzten Tumoren durch die Standardresektionen (partielle Pankreatikoduodenektomie, distale Pankreatektomie, totale Pankreatikoduodenektomie) mit entsprechender Lymphadenektomie erfolgen. Sind die venösen mesenterico-portalen Gefäßstrukturen oder Nachbarorgane per continuitatem betroffen, ist eine kurative Resektion ebenfalls meist mit etwas erhöhter Morbidität, aber gleichwertigem onkologischem Outcome möglich. Eine Infiltration arterieller Gefäße (T4-Situation) und das Vorliegen von Metastasen stellen grundsätzliche Kontraindikationen für eine Resektion dar, da das onkologische Outcome keinen eindeutigen Vorteil für die Patienten zeigt. Jede chirurgische Therapie beim Pankreaskarzinom muss in ein interdisziplinäres onkologisches Konzept eingebunden sein, wobei die adjuvante Chemotherapie hier den größten Stellenwert hat.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Literatur
Adler G, Seufferlein T, Bischoff SC et al (2007) S3-Guidelines „Exocrine pancreatic cancer“ 2007. Z Gastroenterol 45: 487–523
Amin S, Lucas AL, Frucht H (2013) Evidence for treatment and survival disparities by age in pancreatic adenocarcinoma: a population-based analysis. Pancreas 42(2): 249–253
Bockhorn M, Burdelski C, Bogoevski D (2011) Arterial en bloc resection for pancreatic carcinoma. Br J Surg 98(1): 86–92
Diener MK, Fitzmaurice C, Schwarzer G, Seiler CM, Antes G, Knaebel HP, Büchler MW (2011) Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database Syst Rev 5: CD006053
Diener MK, Seiler CM, Rossion I et al (2011) Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial. Lancet 377(9776): 1514–1522
Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, Friess H, Schirmacher P, Büchler MW (2008) Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 15(6): 1651–1660
Grenacher L, Klauss M (2009) Computed tomography of pancreatic tumors. Radiologe 49(2): 107–123
Gudjonsson B (2009) Pancreatic cancer: survival, errors and evidence. Eur J Gastroenterol Hepatol 21(12): 1379–1382
Hartwig W, Hackert T, Hinz U et al (2009) Multivisceral resection for pancreatic malignancies: risk-analysis and long-term outcome. Ann Surg 250(1): 81–87
Hishinuma S, Ogata Y, Tomikawa M, Ozawa I, Hirabayashi K, Igarashi S (2006) Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg 10(4): 511–518
Kawai M, Tani M, Hirono S, Miyazawa M, Shimizu A, Uchiyama K, Yamaue H (2011) Pylorus ring resection reduces delayed gastric emptying in patients undergoing pancreatoduodenectomy: a prospective, randomized, controlled trial of pylorus-resecting versus pylorus-preserving pancreatoduodenectomy. Ann Surg 253(3): 495–501
Klempnauer J, Ridder GJ, Piso P, Pichlmayr R (1996) Is liver resection in metastases of exocrine pancreatic carcinoma justified? Chirurg 67(4): 366–370
Köninger J, Wente MN, Müller-Stich BP, di Mola FF, Gutt CN, Hinz U, Müller MW, Friess H, Büchler MW (2008) R2 resection in pancreatic cancer – does it make sense? Langenbecks Arch Surg 393(6): 929–934
Makary MA, Winter JM, Cameron JL, Campbell KA, Chang D, Cunningham SC, Riall TS, Yeo CJ (2006) Pancreaticoduodenectomy in the very elderly. J Gastrointest Surg 10(3): 347–356
Michalski CW, Kleeff J, Wente MN, Diener MK, Büchler MW, Friess H (2007) Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg 94(3): 265–273
Mitchem JB, Hamilton N, Gao F, Hawkins WG, Linehan DC, Strasberg SM (2012) Long-term results of resection of adenocarcinoma of the body and tail of the pancreas using radical antegrade modular pancreatosplenectomy procedure. J Am Coll Surg 214(1): 46–52
Mollberg N, Rahbari NN, Koch M et al (2011) Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Ann Surg 254(6): 882–893
Nentwich MF, Bockhorn M, König A, Izbicki JR, Cataldegirmen G (2012) Surgery for advanced and metastatic pancreatic cancer – current state and trends. Anticancer Res 32(5): 1999–2002
Neoptolemos JP, Stocken DD, Friess H et al (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350(12): 1200–1210
Pedrazzoli S, DiCarlo V, Dionigi R, Mosca F, Pederzoli P, Pasquali C, Klöppel G, Dhaene K, Michelassi F (1998) Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 228(4): 508–517
Poultsides GA, Reddy S, Cameron JL, Hruban RH, Pawlik TM, Ahuja N, Jain A, Edil BH, Iacobuzio-Donahue CA, Schulick RD, Wolfgang CL (2010) Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas. Ann Surg 251(3): 470–476
Rau BM, Moritz K, Schuschan S, Alsfasser G, Prall F, Klar E (2012) R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use. Surgery 152(3 Suppl 1): S103–111
Schmidt J, Abel U, Debus J, Harig S, Hoffmann K, Herrmann T, Bartsch D, Klein J, Mansmann U, Jäger D, Capussotti L, Kunz R, Büchler MW (2012) Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma. J Clin Oncol 30(33): 4077–4083
Shrikhande SV, Kleeff J, Reiser C, Weitz J, Hinz U, Esposito I, Schmidt J, Friess H, Büchler MW (2007) Pancreatic resection for M1 pancreatic ductal adenocarcinoma. Ann Surg Oncol 14(1): 118–127. Epub 2006 Oct 25
Simianu VV, Zyromski NJ, Nakeeb A, Lillemoe KD (2010) Pancreatic cancer: progress made. Acta Oncol 49(4): 407–417
Siriwardana HP, Siriwardena AK (2006) Systematic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer. Br J Surg 93(6): 662–673
Song KB, Kim SC, Park JB, Kim YH, Jung YS, Kim MH, Lee SK, Seo DW, Lee SS, Park do H, Han DJ (2011) Single-center experience of laparoscopic left pancreatic resection in 359 consecutive patients: changing the surgical paradigm of left pancreatic resection. Surg Endosc 25(10): 3364–3372
Strobel O, Hartwig W, Hackert T, Hinz U, Berens V, Grenacher L, Bergmann F, Debus J, Jäger D, Büchler M, Werner J (2013) Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival. Ann Surg Oncol 20(3): 964–972
Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, Anthoney A (2006) Redefining the R1 resection in pancreatic cancer. Br J Surg 93(10): 1232–1237
Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Büchler MW (2004) Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91(5): 586–594
Welsch T, Borm M, Degrate L, Hinz U, Büchler MW, Wente MN (2010) Evaluation of the International Study Group of Pancreatic Surgery definition of delayed gastric emptying after pancreatoduodenectomy in a high-volume centre. Br J Surg 97(7): 1043–1050
Yeo CJ, Cameron JL, Sohn TA, Coleman J, Sauter PK, Hruban RH, Pitt HA, Lillemoe KD (1999) Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg 229(5): 613–622
Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA, Hruban RH, Ord SE, Sauter PK, Coleman J, Zahurak ML, Grochow LB, Abrams RA (1997) Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 226(3): 248–257
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hackert, T., Hartwig, W. (2013). Indikation zur Resektion beim Pankreaskarzinom – Wann ist eine Resektion vorteilhaft für den Patienten?. In: Beger, H., et al. Erkrankungen des Pankreas. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-37964-2_68
Download citation
DOI: https://doi.org/10.1007/978-3-642-37964-2_68
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-37963-5
Online ISBN: 978-3-642-37964-2
eBook Packages: Medicine (German Language)